SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Pacira BioSciences Q1 EPS $0.530 Beats $0.320 Estimate, Sales $105.700M Beat $102.970M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.530 per share which beat the analyst consensus estimate of $0.320 by 65.63 percent. This is a 140.91 percent increase over earnings of $0.220 per share

Benzinga · 05/07/2020 12:05

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.530 per share which beat the analyst consensus estimate of $0.320 by 65.63 percent. This is a 140.91 percent increase over earnings of $0.220 per share from the same period last year. The company reported quarterly sales of $105.700 million which beat the analyst consensus estimate of $102.970 million by 2.65 percent. This is a 15.76 percent increase over sales of $91.313 million the same period last year.